Dr Reddy’s gets 4 observations from USFDA for Telangana plant Industry-The Economic Times — March 16, 2018 comments off US health regulator has issued four observations after inspecting Dr Reddy’s active pharmaceutical ingredients (API) facility in Telangana.
US health regulator has issued four observations after inspecting Dr Reddy’s active pharmaceutical ingredients (API) facility in Telangana.